Pancreatic Cancer Research

Journal articleBiomed Rep2023

Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells.

Journal
Biomed Rep
Published
1 June 2023
Citations
5
Type
Article
License
cc by-nc-nd

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc-nd

Gemcitabine is a chemotherapeutic agent for pancreatic cancer treatment. It has also been demonstrated to inhibit human pancreatic cancer cell lines, MIA PaCa-2 and PANC-1. … Excerpt only: this text is the publisher’s. Read it in full at the source.